Patent details

EP2170930 Title: AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS

Basic Information

Publication number:
EP2170930
PCT Application Number:
PCT/US/2008/065824
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087701355
PCT Publication Number:
WO/2008/151257
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
French Title of Invention:
AGONISTES DE GUANYLASE CYCLASE UTILES POUR LE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX, D'INFLAMMATION, DE CANCER ET D'AUTRES TROUBLES
German Title of Invention:
FÜR DIE BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN, ENTZÜNDUNGEN, KREBS UND ANDEREN ERKRANKUNGEN GEEIGNETE AGONISTEN VON GUANYLATCYCLASE
SPC Number:

Dates

Filing date:
04/06/2008
Grant date:
15/08/2012
EP Publication Date:
15/08/2012
PCT Publication Date:
11/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2010
EP B1 Publication Date:
15/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/06/2013
Expiration date:
04/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/06/2008
 
 

Name:
Synergy Pharmaceuticals Inc.
Address:
420 Lexington Avenue Suite 1609, New York, NY 10170, United States (US)

Inventor

1

Name:
JACOB Gary, S.
Address:
United States (US)

2

Name:
SHAILUBHAI Kunwar
Address:
United States (US)

Priority

Priority Number:
933194 P
Priority Date:
04/06/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 7/08;
Filing date Document type Number of pages